HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indoxyl sulfate suppresses endothelial progenitor cell-mediated neovascularization.

Abstract
Patients with chronic kidney disease have an increased prevalence of peripheral arterial disease. Endothelial progenitor cells (EPC) are pivotal in neovascularization, but their role in mediating peripheral arterial disease in chronic kidney disease is not fully known. Here we studied the impact of indoxyl sulfate, a protein-bound uremic toxin, on EPC function in response to tissue ischemia or cell hypoxia in mice that underwent subtotal nephrectomy or sham operation. At 16 weeks, unilateral hindlimb ischemia was induced in all. Four weeks later, subtotal nephrectomy mice had significantly increased plasma levels of indoxyl sulfate, reduced reperfusion, decreased EPC mobilization, and impaired neovascularization in ischemic hindlimbs compared with control mice. Treatment with AST-120, an oral adsorbent of uremic toxins, reversed these changes. Ischemia-induced protein expression including phospho-eNOS, phospho-STAT3, interleukin-10, and VEGF were significantly decreased in ischemic hindlimbs of subtotal nephrectomy mice versus control mice; all effects were reversed by AST-120. Subtotal nephrectomy mice fed a diet with indole for 12 weeks resulted in impaired neovascularization in ischemic hindlimbs; also reversed by AST-120. In cultured human EPCs, VEGF expression was increased in hypoxia through HIF-1α and interleukin-10/STAT3 signaling; effects suppressed by pretreatment with indoxyl sulfate. Moreover, indoxyl sulfate markedly attenuated hypoxia-induced EPC migration and tube formation. Thus, indoxyl sulfate may be a therapeutic target for EPC-rescue of impaired neovascularization in patients with chronic kidney disease and peripheral arterial disease.
AuthorsSzu-Chun Hung, Ko-Lin Kuo, Hsin-Lei Huang, Chia-Chun Lin, Tung-Hu Tsai, Chao-Hung Wang, Jaw-Wen Chen, Shing-Jong Lin, Po-Hsun Huang, Der-Cherng Tarng
JournalKidney international (Kidney Int) Vol. 89 Issue 3 Pg. 574-85 (Mar 2016) ISSN: 1523-1755 [Electronic] United States
PMID26880454 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Angiogenic Proteins
  • Inflammation Mediators
  • Oxides
  • Carbon
  • AST 120
  • Indican
Topics
  • Angiogenic Proteins (genetics, metabolism)
  • Animals
  • Bone Marrow Transplantation
  • Carbon (pharmacology)
  • Cell Movement (drug effects)
  • Cells, Cultured
  • Disease Models, Animal
  • Endothelial Progenitor Cells (drug effects, metabolism, pathology)
  • Gene Expression Regulation
  • Hindlimb
  • Humans
  • Indican (blood)
  • Inflammation Mediators (metabolism)
  • Ischemia (blood, genetics, pathology, physiopathology)
  • Male
  • Mice, Inbred C57BL
  • Muscle, Skeletal (blood supply)
  • Neovascularization, Physiologic (drug effects)
  • Nephrectomy
  • Oxides (pharmacology)
  • Regional Blood Flow
  • Signal Transduction
  • Time Factors
  • Transfection
  • Up-Regulation
  • Uremia (blood, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: